| World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access |
| Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc |
| Journal website https://www.wjon.org |
Original Article
Volume 14, Number 2, April 2023, pages 150-157
Quality of Life Impacts Following Surgery for Advanced Head and Neck Cancer
Tables
| HADS (anxietyb) | HADS (depressionb) | SCNS (psychological needs)c | SCNS (physical and daily living needs)c | EORTC (fear of progression)c | EORTC (body image)c | FACE-Q (speaking) | FACE-Q (appearance distress) | IPA (work and education)c | |
|---|---|---|---|---|---|---|---|---|---|
| *P < 0.05. **P < 0.01. aCorrelation (Pearson’s r); N = 27. bn = 1 missing data. cn ≤ 4 missing data. | |||||||||
| Age | -0.232 | -0.068 | -0.183 | -0.031 | -0.082 | -0.188 | 0.253 | 0.230 | 0.471* |
| Time since operation | -0.165 | -0.533** | -0.415* | -0.527** | -0.284 | -0.298 | 0.152 | 0.384 | -0.294 |
| Length of operation | 0.079 | 0.442* | 0.202 | 0.135 | 0.388 | 0.299 | -0.142 | -0.262 | 0.424* |
| Length of stay | 0.223 | 0.435* | 0.241 | -0.038 | 0.225 | 0.378 | -0.456* | 0.023 | 0.119 |
| Comorbidity Index | -0.196 | 0.045 | -0.032 | 0.138 | 0.008 | -0.053 | 0.248 | 0.069 | 0.456* |
| Estimated 10-year survival | 0.187 | -0.089 | 0.049 | -0.121 | -0.034 | 0.044 | -0.221 | -0.030 | -0.523* |
| Mean | SD | ||||
|---|---|---|---|---|---|
| Age (years) | 62.6 | 13.8 | |||
| Time since operation (days) | 801.1 | 413.8 | |||
| Length of operation (min) | 497.0 | 124.6 | |||
| Length of stay (days) | 15.8 | 10.1 | |||
| Comorbidity Index (maximum of 37 points) | 4.2 | 1.3 | |||
| Estimated 10-year survival (%) | 46.2 | 31.3 | |||
| n | % | ||||
| aN = 27, no missing data. SD: standard deviation; n: number. | |||||
| Sex | |||||
| Male | 15 | 55.6 | |||
| Female | 12 | 44.4 | |||
| Flap type | |||||
| Radial forearm | 12 | 44.4 | |||
| Anterolateral thigh | 9 | 33.3 | |||
| Fibula | 5 | 18.5 | |||
| Latissimus dorsi | 1 | 3.7 | |||
| Treatment type | |||||
| Surgery alone | 10 | 37.0 | |||
| Surgery plus radiotherapy | 15 | 55.6 | |||
| Surgery plus combination (chemotherapy and radiotherapy) | 2 | 7.4 | |||
| Cancer type | |||||
| Squamous cell carcinoma | 24 | 88.9 | |||
| Basal cell carcinoma | 1 | 3.7 | |||
| Mucoepidermoid carcinoma | 1 | 3.7 | |||
| Papillary thyroid carcinoma | 1 | 3.7 | |||
| Cancer stage | |||||
| T stage 1 | 11 | 40.7 | |||
| T stage 2 | 3 | 11.1 | |||
| T stage 3 | 8 | 29.6 | |||
| T stage 4 | 5 | 18.5 | |||